Stevenage, United Kingdom

Simon Gaines

This inventor holds 8 USPTO granted patents and 3 published patent applications and 6 EPO patents. Top assignees: Glaxo Group Limited, Glaxosmithkline Intellectual Property Development Limited, Glaxogrouplimited. Active years: 2007-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Simon Gaines. Retrieved from https://idiyas.com/inventor/simon-gaines

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 37.5

 

Average Co-Inventor Count = 5.5

ph-index = 3

Forward Citations = 45(Granted Patents)


Company Filing History:


Years Active: 2007-2014

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Simon Gaines

Introduction

Simon Gaines is a notable inventor based in Stevenage, GB, recognized for his significant contributions to the field of pharmaceuticals. With a total of eight patents to his name, Gaines has made remarkable strides in developing compounds that inhibit PI3-kinase activity, which is crucial in various biological processes.

Latest Patents

Gaines' latest patents include innovative compounds directed towards inhibiting PI3-kinase activity. One of his inventions focuses on compounds of formula (I) and their salts, showcasing their potential as effective inhibitors. Another patent involves benzpyrazol derivatives, which are also designed to inhibit PI3-kinase activity, further emphasizing his commitment to advancing medical science through his research.

Career Highlights

Throughout his career, Simon Gaines has worked with prominent companies such as Glaxo Group Limited and GlaxoSmithKline Intellectual Property Development Limited. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Gaines has collaborated with esteemed colleagues, including Ian Robert Baldwin and Kenneth David Down. These partnerships have likely enhanced his research capabilities and led to the development of innovative solutions in his field.

Conclusion

In summary, Simon Gaines is a distinguished inventor whose work in developing PI3-kinase inhibitors has made a significant impact in the pharmaceutical industry. His dedication to innovation and collaboration continues to drive advancements in medical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…